Clients represented
by our firm filed the first personal injury
lawsuits in the nation against Medtronic.
We have been appointed to a leadership
role among plaintiffs' counsel in the litigation
against Medtronic in federal court.
Our
injury lawyers have years of experience
successfully representing clients in personal
injury cases. We provide each client with
high-level individualized representation.
There is no charge or obligation for our review
of your injury lawsuit.
We have retained product safety and medical experts
nationwide to assist our clients with their claims.
In addition to a team of experienced lawyers,
we have dedicated nurses, legal assistants
and case clerks to assist our attorneys in
the Medtronic recall litigation. Our firm
has six full-time nurses, including ones
with decades of experience working with heart
patients.
Free Case
Evaluation
Lieff Cabraser represents
persons across America injured by the
Medtronic Sprint Fidelis heart lead. Click
here to contact an experienced injury
attorney at Lieff Cabraser for a free
case evaluation. Or call us toll-free
at 1-800-948-2181.
Medtronic News
Read excerpts from the latest
news covering the Medtronic recall and lawsuits:
Lieff Cabraser had
been investigating patient complaints
concerning the Medtronic heart lead prior
to the recall announced by Medtronic. On
the same day as the recall, heart patients
nationwide represented by Lieff Cabraser
and co-counsel filed separate personal
injury and class action lawsuits against
Medtronic.
Medtronic Inc. has stopped distributing
Sprint Fidelis defibrillation leads because
of the possibility that these leads could
fracture in a small percentage of patients.
Although the leads continue to function properly
in the vast majority of patients, if one
does fracture, the defibrillator could deliver
unnecessary shocks or not operate at all.
Some deaths and major complications have
occurred when the leads fractured.
The affected products are Sprint Fidelis
Models 6930, 6931, 6948, and 6949. They are
used with implantable cardioverter-defibrillators
(ICD) or cardiac resynchronization therapy
defibrillators (CRT-D). Medtronic is advising
physicians to stop implanting the leads and
to return unused leads to the company. FDA
and Medtronic are not recommending prophylactic
removal of the leads in most patients, because
the risk of removing the lead exceeds the
small risk of a fracture.
In addition, the company recommends reprogramming
the device to monitor the patient more effectively
for potential problems, and to provide an
audible alert if a lead does fracture. Patients
who have the Sprint Fidelis lead should contact
their physician, especially if they have
experienced multiple shocks, lightheadedness,
fainting, or palpitations. Patients should
also recognize that a small number of Sprint
Fidelis leads are used with defibrillators
made by manufacturers other than Medtronic.
If patients think they have a Sprint Fidelis
lead, or if they do not know the model of
their lead, they should contact their doctor.
About Lieff Cabraser
Founded in 1972, Lieff Cabraser Heimann & Bernstein, LLP is
an over fifty attorney law firm with offices in San Francisco, New
York and Nashville. For the last five years, the National
Law Journal has recognized Lieff Cabraser as one of the top plaintiff law firms
in America.
To learn more about the advantages our lawyers
offer clients in personal injury and wrongful death cases, click
here.
TRADEMARK NOTICE: "Medtronic" is
a trademark of Medtronic, Inc. Lieff Cabraser
is in no way affiliated with Medtronic, Inc. The use of this
mark is solely for informational and product identification purposes.
